相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence and admission rates for severe malaria and their impact on mortality in Africa
Flavia Camponovo et al.
MALARIA JOURNAL (2017)
Glucuronidation: driving factors and their impact on glucuronide disposition
Guangyi Yang et al.
DRUG METABOLISM REVIEWS (2017)
The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine
M. Neary et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients
T. Kredo et al.
BMC INFECTIOUS DISEASES (2016)
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks
Kimberly K. Scarsi et al.
CLINICAL INFECTIOUS DISEASES (2016)
CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients
B. A. Maganda et al.
PHARMACOGENOMICS JOURNAL (2016)
Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB
Faiz Ahmad Khan et al.
CLINICAL INFECTIOUS DISEASES (2016)
Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
Eskouhie Tchaparian et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Treatment of Malaria in Pregnancy
Joel Tarning
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Four Artemisinin-Based Treatments in African Pregnant Women with Malaria
D. Pekyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy
Sunil Parikh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications
Richard M. Hoglund et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Pharmacogenetics of Pregnancy-Induced Changes in Efavirenz Pharmacokinetics
A. Olagunju et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Pharmacokinetics of Efavirenz and Treatment of HIV-1 Among Pregnant Women With and Without Tuberculosis Coinfection
Kelly E. Dooley et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Method development and validation for simultaneous determination of lumefantrine and its major metabolite, desbutyl lumefantrine in human plasma using RP-HPLC/UV detection
Fazli Khuda et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2014)
Physiologic and pharmacokinetic changes in pregnancy
Maged M. Costantine
FRONTIERS IN PHARMACOLOGY (2014)
Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda
Joel Tarning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Malaria in Pregnancy
Ebako Ndip Takem et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2013)
Quantitative Prediction of CYP2B6 Induction by Estradiol During Pregnancy: Potential Explanation for Increased Methadone Clearance During Pregnancy
Leslie J. Dickmann et al.
DRUG METABOLISM AND DISPOSITION (2013)
Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda
F. Kloprogge et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Efavirenz Pharmacokinetics During the Third Trimester of Pregnancy and Postpartum
Tim R. Cressey et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults
Pauline Byakika-Kibwika et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Determination of lumefantrine in small-volume human plasma by LC-MS/MS: using a deuterated lumefantrine to overcome matrix effect and ionization saturation
Liusheng Huang et al.
BIOANALYSIS (2012)
Consequences of HIV infection on malaria and therapeutic implications: a systematic review
Clara Flateau et al.
LANCET INFECTIOUS DISEASES (2011)
Efavirenz Primary and Secondary Metabolism In Vitro and In Vivo: Identification of Novel Metabolic Pathways and Cytochrome P450 2A6 as the Principal Catalyst of Efavirenz 7-Hydroxylation
Evan T. Ogburn et al.
DRUG METABOLISM AND DISPOSITION (2010)
CYP2D6 Mediates 4-Hydroxylation of Clonidine In Vitro: Implication for Pregnancy-Induced Changes in Clonidine Clearance
Adam J. Claessens et al.
DRUG METABOLISM AND DISPOSITION (2010)
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial
Patrice Piola et al.
LANCET INFECTIOUS DISEASES (2010)
Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
Jessica Mwinyi et al.
MOLECULAR PHARMACOLOGY (2010)
Clinical pharmacology of artemisinin-based combination therapies
Francesca T. Aweeka et al.
CLINICAL PHARMACOKINETICS (2008)
Simplified antimalarial therapeutic monitoring: using the day-7 drug level?
Nicholas J. White et al.
TRENDS IN PARASITOLOGY (2008)
A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy
Rose McGready et al.
PLOS MEDICINE (2008)
Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases
KF Ilett et al.
DRUG METABOLISM AND DISPOSITION (2002)
分享论文
